Atlantic Private Wealth’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
Atlantic Private Wealth's XERS Position: Q3 2026 in Review
Atlantic Private Wealth held its Xeris Biopharma Holdings (XERS) position steady in Q3 2026 at 30 shares worth $287. The position accounts for ﹤0.01% of the portfolio, ranked #293.
Atlantic Private Wealth first reported a position in XERS in Q4 2025 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold XERS as of Q3 2026.
- Atlantic Private Wealth held 30 shares of Xeris Biopharma Holdings worth $287 as of Q3 2026.
- Atlantic Private Wealth left its Xeris Biopharma Holdings share count unchanged in Q3 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of Atlantic Private Wealth's portfolio in Q3 2026, its #293 holding.
- Atlantic Private Wealth first reported a position in Xeris Biopharma Holdings in Q4 2025 and has held it in 4 quarters since.
- 182 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2026.
Based on Atlantic Private Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.